ADC Therapeutics SA (ADCT) Tops Q1 EPS by 17c

ADC Therapeutics SA (NYSE: ADCT) reported Q1 EPS of ($0.38), $0.17 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $17.87 million.

For earnings history and earnings-related data on ADC Therapeutics SA (ADCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c